Robbie Williams is losing his eyesight – and blames weight loss jabs - The singer and former Take That member said in 2023 ...

Dr Crystal Wyllie says there is a scientific reason behind wanting to eat more during the colder months - and explains how to ...

It's not uncommon for people to up their appetites in the colder months, but is there a real reason why? A Doctor has ...

Shares of Novo Nordisk A/S (NYSE: NVO) dropped 1.9%today, closing at $48.25, just a whisker above the 52-week low of $45.05.

A forthcoming HSE assessment will determine who qualifies for Mounjaro, with access likely restricted to high-risk patients due to cost ...

People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...

Novo Nordisk A/S remains attractive with strong cash flow and robust pipeline. Click here to read why NVO stock is a Buy.

Newly-elected chairman of Wegovy-maker Novo Nordisk , Lars Rebien Sorensen, said on Friday he plans to enhance the board's ...